Nothing Without Us: Civil Society Solutions to the COVID-19 Pandemic

Assessment of Needs

The COVID-19 pandemic has created an unprecedented disruption in life as we know it, affecting not only the public health of communities worldwide but our economic and social wellbeing.

Similar to some 40 years ago, the global HIV community of advocates and activists are leading the charge in the grassroots community response against this devastating new pandemic. Our accumulated experience and skills will be the key to finding solutions and providing support to those who are the most overlooked and affected among us.

The COVID Advocates Advisory Board is a group of civil society organizations and global health advocates committed to bringing communities together and, by gleaning insight from HIV activism, setting the path toward resolving the inequities that COVID-19 has exacerbated.

This session brings together the experience of fierce  HIV and COVID-19 advocates from grassroots organizations around the globe with shared and vital goals of learning from one another, defining best practices, valuing the role of communities, and demanding accountability in the fight for equity in the global COVID-19 response. We invite you to join us for a robust, interactive discussion on these topics.

Learning Objectives

On completion of this webinar, learners will be able to:

• Identify strategies and initiatives being done globally by community advocates and members to address the COVID-19 pandemic
• Describe the interactions and parallels in HIV and COVID-19 advocacy

Registration

Who Should Attend

This webinar is designed for clinical decision makers and community members who are actively involved in HIV and COVID-19 care, research, and advocacy.

This activity is also relevant for nursing professionals, physician assistants, pharmacists, and other health care professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Tuesday, June 22, 2021, 6:00 AM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.